J. M. Vicent - Concepedia

Author

J. M. Vicent

Hospital General Universitario De Valencia

Also Known As

J M Vicent, J. M. Vicent, J. Vicent, J.M. Vicent, Jose M. Vicent, Jose Maria Vicent, José M. Vicent, José María Vicent

Publications

353

Citations

H-Index

Concepts

All Affiliations

Hospital General Universitario De Valencia Hospital Virgen de los Lirios Hospital General de Elda Fundación Instituto Valenciano de Oncología Fundación Hospital Provincial de Castellón

About

J. M. Vicent is an author at Hospital General Universitario De Valencia specializing in cancer therapeutics, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	69
2	Pathology	2	2	45
3	Pharmacology	2	2	45
4	Health Sciences	1	1	24
5	Surgical Oncology	1	1	13

J. M. Vicent

Publications

313

Citations

H-Index

Page 1

	Year	Citations
Irinotecan in Combination With Fluorouracil in a 48-Hour Continuous Infusion As First-Line Chemotherapy for Elderly Patients With Metastatic Colorectal Cancer: A Spanish Cooperative Group for the Treatment of Digestive Tumors Study Javier Sastre, Eugenio Marcuello, B. Masutti, Journal of Clinical Oncology	2005	98
Preoperative Uracil, Tegafur, and Concomitant Radiotherapy in Operable Rectal Cancer: A Phase II Multicenter Study With 3 Years' Follow-Up Carlos Fernández-Martos, Jorge Aparicio, Carles Bosch, Journal of Clinical Oncology	2004	70
Phase II trial of gemcitabine and UFT modulated by leucovorin in patients with advanced pancreatic carcinoma Jaime Feliú, M. P. L�pez �lvarez, M. A. Jaraiz, Cancer	2000	34
FOLFOX Alternated with FOLFIRI as First-Line Chemotherapy for Metastatic Colorectal Cancer Jorge Aparicio, Carlos Fernández-Martos, J. M. Vicent, Clinical Colorectal Cancer OncologyGastrointestinal OncologyMedicinePathologyColorectal Cancer	2005	32
Multicenter phase II trial evaluating a three-weekly schedule of irinotecan plus raltitrexed in patients with 5-fluorouracil-refractory advanced colorectal cancer Jorge Aparicio, J. M. Vicent, I. Maestu, Annals of Oncology Gastrointestinal OncologyMedicineColorectal CancerPharmacotherapyThree-weekly Schedule	2003	24
Phase II study of UFT and oxaliplatin in first-line treatment of advanced colorectal cancer Jaime Feliú, J. M. Vicent, Carlos García Girón, British Journal of Cancer	2004	18
First-Line Treatment with Irinotecan and Raltitrexed in Metastatic Colorectal Cancer Jorge Aparicio, J. M. Vicent, I. Maestu, Oncology	2005	14
Phase II Study of Cisplatin, 5-Fluorouracil, and Leucovorin in Inoperable Squamous Cell Carcinoma of the Esophagus M. González Barón, Carlos García Girón, Enrique Espinosa, American Journal of Clinical Oncology Surgical OncologyEsophagusEsophageal CancerGastrointestinal OncologyP 20	1996	13
A phase II study of capecitabine (X) in elderly patients (p) as 1st line treatment for patients (pts) with advanced or metastatic colorectal cancer (MCRC) Jesús Feliu, P. Escudero, Ferrán Losa, Journal of Clinical Oncology	2004	10

Page 1